Cargando…
Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Science China Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816738/ https://www.ncbi.nlm.nih.gov/pubmed/33471276 http://dx.doi.org/10.1007/s11427-020-1871-4 |
| _version_ | 1783638501775900672 |
|---|---|
| author | Li, Qiuyu Cui, Cheng Xu, Fei Zhao, Jianping Li, Nan Li, Haichao Wang, Tianbing Zhang, Hua Liu, Na Wei, Yudong Niu, Xiaoye Xu, Yan Dong, Jianping Yao, Xueting Wang, Xiaohong Chen, Yahong Li, Haiyan Song, Chunli Qiao, Jie Liu, Dongyang Shen, Ning |
| author_facet | Li, Qiuyu Cui, Cheng Xu, Fei Zhao, Jianping Li, Nan Li, Haichao Wang, Tianbing Zhang, Hua Liu, Na Wei, Yudong Niu, Xiaoye Xu, Yan Dong, Jianping Yao, Xueting Wang, Xiaohong Chen, Yahong Li, Haiyan Song, Chunli Qiao, Jie Liu, Dongyang Shen, Ning |
| author_sort | Li, Qiuyu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7816738 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Science China Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78167382021-01-21 Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19 Li, Qiuyu Cui, Cheng Xu, Fei Zhao, Jianping Li, Nan Li, Haichao Wang, Tianbing Zhang, Hua Liu, Na Wei, Yudong Niu, Xiaoye Xu, Yan Dong, Jianping Yao, Xueting Wang, Xiaohong Chen, Yahong Li, Haiyan Song, Chunli Qiao, Jie Liu, Dongyang Shen, Ning Sci China Life Sci Letter to the Editor Science China Press 2021-01-18 2021 /pmc/articles/PMC7816738/ /pubmed/33471276 http://dx.doi.org/10.1007/s11427-020-1871-4 Text en © Science China Press and Springer-Verlag GmbH Germany, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Li, Qiuyu Cui, Cheng Xu, Fei Zhao, Jianping Li, Nan Li, Haichao Wang, Tianbing Zhang, Hua Liu, Na Wei, Yudong Niu, Xiaoye Xu, Yan Dong, Jianping Yao, Xueting Wang, Xiaohong Chen, Yahong Li, Haiyan Song, Chunli Qiao, Jie Liu, Dongyang Shen, Ning Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19 |
| title | Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19 |
| title_full | Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19 |
| title_fullStr | Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19 |
| title_full_unstemmed | Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19 |
| title_short | Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19 |
| title_sort | evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with covid-19 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816738/ https://www.ncbi.nlm.nih.gov/pubmed/33471276 http://dx.doi.org/10.1007/s11427-020-1871-4 |
| work_keys_str_mv | AT liqiuyu evaluationoftheefficacyandsafetyofhydroxychloroquineincomparisonwithchloroquineinmoderateandseverepatientswithcovid19 AT cuicheng evaluationoftheefficacyandsafetyofhydroxychloroquineincomparisonwithchloroquineinmoderateandseverepatientswithcovid19 AT xufei evaluationoftheefficacyandsafetyofhydroxychloroquineincomparisonwithchloroquineinmoderateandseverepatientswithcovid19 AT zhaojianping evaluationoftheefficacyandsafetyofhydroxychloroquineincomparisonwithchloroquineinmoderateandseverepatientswithcovid19 AT linan evaluationoftheefficacyandsafetyofhydroxychloroquineincomparisonwithchloroquineinmoderateandseverepatientswithcovid19 AT lihaichao evaluationoftheefficacyandsafetyofhydroxychloroquineincomparisonwithchloroquineinmoderateandseverepatientswithcovid19 AT wangtianbing evaluationoftheefficacyandsafetyofhydroxychloroquineincomparisonwithchloroquineinmoderateandseverepatientswithcovid19 AT zhanghua evaluationoftheefficacyandsafetyofhydroxychloroquineincomparisonwithchloroquineinmoderateandseverepatientswithcovid19 AT liuna evaluationoftheefficacyandsafetyofhydroxychloroquineincomparisonwithchloroquineinmoderateandseverepatientswithcovid19 AT weiyudong evaluationoftheefficacyandsafetyofhydroxychloroquineincomparisonwithchloroquineinmoderateandseverepatientswithcovid19 AT niuxiaoye evaluationoftheefficacyandsafetyofhydroxychloroquineincomparisonwithchloroquineinmoderateandseverepatientswithcovid19 AT xuyan evaluationoftheefficacyandsafetyofhydroxychloroquineincomparisonwithchloroquineinmoderateandseverepatientswithcovid19 AT dongjianping evaluationoftheefficacyandsafetyofhydroxychloroquineincomparisonwithchloroquineinmoderateandseverepatientswithcovid19 AT yaoxueting evaluationoftheefficacyandsafetyofhydroxychloroquineincomparisonwithchloroquineinmoderateandseverepatientswithcovid19 AT wangxiaohong evaluationoftheefficacyandsafetyofhydroxychloroquineincomparisonwithchloroquineinmoderateandseverepatientswithcovid19 AT chenyahong evaluationoftheefficacyandsafetyofhydroxychloroquineincomparisonwithchloroquineinmoderateandseverepatientswithcovid19 AT lihaiyan evaluationoftheefficacyandsafetyofhydroxychloroquineincomparisonwithchloroquineinmoderateandseverepatientswithcovid19 AT songchunli evaluationoftheefficacyandsafetyofhydroxychloroquineincomparisonwithchloroquineinmoderateandseverepatientswithcovid19 AT qiaojie evaluationoftheefficacyandsafetyofhydroxychloroquineincomparisonwithchloroquineinmoderateandseverepatientswithcovid19 AT liudongyang evaluationoftheefficacyandsafetyofhydroxychloroquineincomparisonwithchloroquineinmoderateandseverepatientswithcovid19 AT shenning evaluationoftheefficacyandsafetyofhydroxychloroquineincomparisonwithchloroquineinmoderateandseverepatientswithcovid19 |